Host-Fungal Interactions Relevant to the Newborn Infant

Fetal and Neonatal Physiology E-Book, Fourth Edition

Volumn , Issue , 2011, Pages 1566-1569

  Maródi, László ^a   Johnston, Richard B ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943415723     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3479-7.10149-1     Document Type: Chapter

References (65)

1. M.A. Pfaller (1994) Epidemiology and control of fungal infections. Clin Infect Dis 19(Suppl 1), S8-13.
2. S.M. Levitz (1992) Overview of host defenses in fungal infections. Clin Infect Dis 14(Suppl 1), S37-S42.
3. R.B. Johnston (1998) Jr: Function and cell biology of neutrophils and mononuclear phagocytes in the newborn infant. Vaccine 16 1363-1368.
4. L. Maródi (2006) Innate cellular immune responses in newborns. Clin Immunol 118 137-144.
5. D.B. Lewis, C.B. Wilson (2006) Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. J.S. Remington, J.O. Klein, C.B. Wilson, et al., (Eds) Infectious Diseases of the Fetus and Newborn Infant ed 6 Philadelphia: Saunders 87-210
6. D.E. Johnson, T. Thompson, T. Green, et al. (1984) Systemic candidiasis in very low-birth-weight infants (less than 1500 grams). Pediatrics 73 138-143.
7. J.E. Baley, R. Kleigman and A. Fanaroff (1984) Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 73 144-152.
8. B.J. Stoll and N. Hansen (2003) Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 27 293-301.
9. S.K. Fridkin, D. Kaufman, J.R. Edwards, et al. (2006) Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117 1680-1687.
10. D.K. Benjamin Jr., B.J. Stoll, A.A. Fanaroff, et al. (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117 84-92.
11. D. Kaufman (2004) Fungal infection in the very low birthweight infant. Curr Opin Infect Dis 17 253-259.
12. G.P. Rabalais, T.D. Samiec, K.K. Bryant, et al. (1996) Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 15 348-352.
13. D.A. Kaufman, M.J. Gurka, K.C. Hazen, et al. (2006) Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J 25 733-737.
14. D.K. Benjamin Jr., K. Ross, D.K. Benjamin, et al. (2000) When to expect fungal infections in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106 712-718.
15. K.D. Fairchild, S. Tomkoria, E.C. Sharp, et al. (2002) Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J 21 39-43.
16. P. Manzoni, D. Farina, M.L. Leonessa, et al. (2006) Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118 2359-2364.
17. L. Maródi (1997) Local and systemic host defense mechanisms against candida: immunopathology of candidal infections. Pediatr Infect Dis J 16 795-801.
18. C.M. Cotten, S. McDonald, B. Stoll, et al. (2006) The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 118 717-722.
19. C.H. Kirkpatrick (2001) Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 20 197-206.
20. C.M. Bendel (2006) Candidiasis. J.S. Remington, J.O. Klein, C.B. Wilson, et al., (Eds) Infectious Diseases of the Fetus and Newborn Infant ed 6 Philadelphia: Saunders 1107-1128.
21. H.J. Lo, J.R. Kohler, B. DiDominico, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90 939-949.
22. M.K. Hostetter (2000) RGD-mediated adhesion in fungal pathogens of humans, plants and insects. Curr Opin Microbiol 3 344-348.
23. D. Hausauer, M. Gerami-Nejad, C. Kistler-Anderson, et al. (2005) Hyphal guidance and invasive growth in Candida albicans require the Ras-like GTPase Rsr1p and its GTPase-activating protein Bud2p. Eukaryot Cell 4 1273-1286.
24. M. Zasloff (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84 5449-5453.
25. M. Zasloff (2006) Defending the epithelium. Nat Med 12 607-608.
26. B. Schittek, R. Hipfel, B. Sauer, et al. (2001) Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2 1133-1137.
27. T. Ganz (2002) Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 109 693-697.
28. K. Putsep, G. Carlsson, H.G. Boman, et al. (2002) Deficiency of antimicrobial peptides in patients with morbus Kostmann: an observation study. Lancet 360 1144-1149.
29. B. Grimbacher, S.M. Holland, J.I. Gallin, et al. (1999) Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Engl J Med 340 692-702.
30. W.L. Whelan, D.R. Kirsch, K.J. Kwon-Chung, et al. (1990) Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel hypervirulent strain. J Infect Dis 162 513-518.
31. C.S. Farah, S. Elahi, G. Pang, et al. (2001) T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect Immun 69 6110-6118.
32. C.B. Wilson, J. Westall, L. Johnston, et al. (1986) Decreased production of interferon gamma by human neonatal cells. J Clin Invest 77 860-867.
33. S.M. Lee, Y. Suen, L. Chang, et al. (1996) Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88 945-954.
34. J.L. Joyner, N.H. Augustine, K.A. Taylor, et al. (2000) Effects of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-γ mRNA accumulation and protein secretion. J Infect Dis 182 974-977.
35. T.R. La Pine, J.L. Joyner, N.H. Augustine, et al. (2003) Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B streptococci. Pediatr Res 54 276-281.
36. C.L. Langrish, J.C. Buddle, A.J. Thrasher, et al. (2002) Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 128 118-123.
37. L. Maródi (2002) Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 128 1-2.
38. S.A. Klotz, D.J. Drutz and J.E. Zajic (1985) Factors governing adherence of Candida species to plastic surfaces. Infect Immun 50 97-101.
39. D. Rotrosen, R.A. Calderone and J.E. Edwards Jr. (1986) Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 8 73-85.
40. J. Stephenson (2001) Can a common medical practice transform Candida infections from benign to deadly? JAMA 286 2531-2532.
41. C.M. Bendel, S.M. Wiesner, R.M. Garni, et al. (2002) Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr Res 51 290-295.
42. B.A. van Rozendaal, A.B. van Spriel, J.G. van De Winkel, et al. (2000) Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 182 917-922.
43. D.A. Hogan and R. Kolter (2002) Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296 2229-2232.
44. J.A. Winkelstein, M.C. Marino, R.B. Johnston Jr., et al. (2000) Chronic granulomatous disease: Report on a national registry of 368 patients. Medicine 79 155-169.
45. R.B. Johnston (2001) Jr: Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 8 17-22.
46. R.I. Lehrer and M.J. Cline (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to candida infection. J Clin Invest 2 135-142.
47. W.M. Nauseef (1988) Myeloperoxidase deficiency. Hematol Oncol Clin North Am 2 135-147.
48. L. Marodi, J.R. Forehand and R.B. Johnston Jr. (1991) Mechanisms of host defense against candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 146 2790-2794.
49. L. Marodi, C. Tournay, R. Kaposzta, et al. (1998) Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect Immun 66 2750-2754.
50. L. Maródi, H.M. Korchak and R.B. Johnston Jr. (1991) Mechanisms of host defense against candida species: I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 146 2783-2789.
51. R. Matthews, J. Burnie, D. Smith, et al. (1988) Candida and AIDS: evidence for protective antibody. Lancet 2 263-266.
52. Y. Han and J.E. Cutler (1995) Antibody response that protects against disseminated candidiasis. Infect Immun 63 2714-2719.
53. Y. Han, T. Kanbe, R. Cherniak, et al. (1997) Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun 65 4100-4107.
54. L. Marodi, S. Schreiber, D.C. Anderson, et al. (1993) Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 91 2596-2601.
55. G. Szolnoky, Z. Bata-Csorgo, A.S. Kenderessy, et al. (2001) A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. J Invest Dermatol 117 205-213.
56. G.D. Brown, J. Herre, D.L. Williams, et al. (2003) Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197 1119-1124.
57. M.G. Netea and L. Maródi (2010) Innate immune mechanisms for recognition and up take of candida species. Trends Immunol 31 346-353.
58. O. Levy, K.A. Zarember, R.M. Roy, et al. (2004) Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173 4627-4634.
59. S.R. Yan, G. Qing, D.M. Byers, et al. (2004) Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 72 1223-1229.
60. L. Maródi, R. Kaposzta, D.E. Campbell, et al. (1994) Candidacidal mechanisms in the human neonate: impaired IFN-γ activation of macrophages in newborn infants. J Immunol 153 5643-5649.
61. L. Maródi, R. Kaposzta and E. Nemes (2000) Survival of group B Streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor. Infect Immun 68 2167-2170.
62. L. Maródi, K. Goda, A. Palicz, et al. (2001) Cytokine receptor signaling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-γ. Clin Exp Immunol 126 456-460.
63. G. Marquis, S. Garzon, S. Montplaisir, et al. (1991) Histochemical and immunochemical study of the fate of Candida albicans inside human neutrophil phagolysosomes. J Leukoc Biol 50 587-599.
64. R. Káposzta, L. Marodi, M. Hollinshead, et al. (1999) Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J Cell Sci 112 3237-3248.
65. M.C. Lorenz and G.R. Fink (2001) The glyoxylate cycle is required for fungal virulence. Nature 412 83-86.